Insider Trading & Ownership - Huber Martin H. Jr.

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Huber Martin H. Jr.

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-02-07
Option Award
2024-02-09
4:04 pm
N/A
N/A
Syndax Pharmaceuticals IncSNDXHuber Martin H. Jr.
Director
17,000$049,000
(Direct)
View
2024-01-15
Option Award
2024-01-17
5:19 pm
N/A
2034-01-14
Mersana Therapeutics Inc.MRSNHuber Martin H. Jr.
President, CEO
243,375$0243,375
(Direct)
View
2023-10-02
Option Award
2023-10-04
4:31 pm
N/A
2033-10-01
Mersana Therapeutics Inc.MRSNHuber Martin H. Jr.
President, CEO
9,102$09,102
(Direct)
View
2023-09-11
Option Award
2023-09-13
4:01 pm
N/A
2033-09-10
Mersana Therapeutics Inc.MRSNHuber Martin H. Jr.
President, CEO
1,667,000$01,667,000
(Direct)
View
2023-08-16
Option Award
2023-08-18
8:30 pm
N/A
2033-08-15
Xilio Therapeutics Inc.XLOHuber Martin H. Jr.
PRESIDENT AND HEAD OF R&D
136,500$0136,500
(Direct)
View
2023-07-03
Option Award
2023-07-06
4:23 pm
N/A
2033-07-02
Mersana Therapeutics Inc.MRSNHuber Martin H. Jr.
Director
4,477$04,477
(Direct)
View
2023-06-08
Option Award
2023-06-12
4:16 pm
N/A
2033-06-07
Mersana Therapeutics Inc.MRSNHuber Martin H. Jr.
Director
32,822$032,822
(Direct)
View
2023-04-03
Option Award
2023-04-05
5:15 pm
N/A
2033-04-02
Mersana Therapeutics Inc.MRSNHuber Martin H. Jr.
Director
3,375$03,375
(Direct)
View
2023-02-02
Option Award
2023-02-03
4:56 pm
N/A
N/A
Syndax Pharmaceuticals IncSNDXHuber Martin H. Jr.
Director
16,000$032,000
(Direct)
View
2023-01-01
Option Award
2023-01-04
4:11 pm
N/A
2032-12-31
Xilio Therapeutics Inc.XLOHuber Martin H. Jr.
PRESIDENT AND HEAD OF R&D
136,500$0136,500
(Direct)
View
2022-06-15
Option Award(A)
2022-06-23
7:30 pm
N/A
2032-06-14
Xilio Therapeutics Inc.XLOHuber Martin H. Jr.
PRESIDENT AND HEAD OF R&D
20,000$020,000
(Direct)
View
2022-06-15
Option Award
2022-06-17
4:31 pm
N/A
2032-06-14
Xilio Therapeutics Inc.XLOHuber Martin H. Jr.
PRESIDENT AND HEAD OF R&D
20,000$020,000
(Direct)
View
2022-06-09
Option Award
2022-06-10
4:18 pm
N/A
2032-06-08
Mersana Therapeutics Inc.MRSNHuber Martin H. Jr.
Director
45,000$045,000
(Direct)
View
2022-02-22
Option Award
2022-02-24
5:30 pm
N/A
2032-02-21
Xilio Therapeutics Inc.XLOHuber Martin H. Jr.
PRESIDENT OF R&D AND CMO
65,000$065,000
(Direct)
View
2022-02-02
Option Award
2022-02-03
5:28 pm
N/A
N/A
Syndax Pharmaceuticals IncSNDXHuber Martin H. Jr.
Director
16,000$016,000
(Direct)
View
2022-01-03
Option Award
2022-01-05
5:05 pm
N/A
2032-01-02
Mersana Therapeutics Inc.MRSNHuber Martin H. Jr.
Director
10,185$010,185
(Direct)
View
2021-10-21
Option Award
2021-10-25
5:17 pm
N/A
2031-10-20
Xilio Therapeutics Inc.XLOHuber Martin H. Jr.
President of R&D and CMO
157,058$0157,058
(Direct)
View

Ownership
2021-10-21
8:40 pm
N/A
2030-07-22
Xilio Therapeutics Inc.XLOHuber Martin H. Jr.
President of R&D and CMO
0$0291,855
(Direct)
View
2021-09-15
Option Award
2021-09-17
4:32 pm
N/A
2031-09-15
Syndax Pharmaceuticals IncSNDXHuber Martin H. Jr.
Director
35,000$19.3635,000
(Direct)
View
2021-06-11
Option Award
2021-06-15
6:01 pm
N/A
2031-06-10
Mersana Therapeutics Inc.MRSNHuber Martin H. Jr.
Director
25,050$025,050
(Direct)
View
2021-01-15
Option Award
2021-01-20
7:02 pm
N/A
2031-01-15
Mersana Therapeutics Inc.MRSNHuber Martin H. Jr.
Director
2,490$02,490
(Direct)
View
2020-04-13
Option Award
2020-06-24
5:07 pm
N/A
2030-04-13
Mersana Therapeutics Inc.MRSNHuber Martin H. Jr.
Director
48,096$048,096
(Direct)
View
(A) Indicate amendment filing.